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Introduction
We report a primary cutaneous follicular center cell lymphoma 
(PCFCCL) with its dermoscopy that arose on face of  a 70-year-
old women who has a son followed for PCFCCL.
This case is unusual because PCFCCL rarely arises on the face, 
and to the best of  our knowledge the hereditary character and the 
dermoscopy of  PCFCCL has so far been published in the English 
literature.
Case Report
A 70 year old women with a family history of  a son followed in 
our hospital for histological proven follicular B Cell lymphoma, 
who underwent surgical resection with good evolution, presented 
with a two months history of  a growing mass on the right parietal 
region.
Physical examination revealed a well-demarcated erythematous 
4*3 cm tumor with hard- elastic consistency, non pulsatile and 
indolent extending in the temporal region (Figure 1).
No lymphadenopathy, abdominal masses, or organomegaly were 
detected. 
In front of  this clinical presentation we thought about many 
diagnosis such us PCFCCL, Extranodal NK cell lymphoma, 
Merkel Carcinoma, Melanoma, Darier disease, Sarcoidosis, 
Pseudolymphoma, Adnexal tumor? and a Foreign body 
granuloma. 
Dermoscopy of  the tumor showed fine short linear vessel, curved 
linear vessel in a spermatozoa-like arrangement and purpuric 
spots based on an erythematous background (Figure 2 ).
Histology showed a diffuse dermal infiltrate of  small lymphocytes 
mixed with large centrocytic/entroblastic cells, partially arranged 
in germinal centers (Figure 3).
Immunohistochemistry revealed positivity of  the large lymphoid 
cell for CD20, and negativity for CD10, CD3 ,CD5, and CD23. 
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There was a low and very focal expression of  Bcl-2 which did 
not express kappa or lambda chains.Moreover, neoplastic B 
cells showed both a high proliferation rate (MIB-1/Ki-67) and 
expression of  nuclear Bcl-6 positivity (Figure 4).
A diagnosis of  cutaneous primitive follicular B cell lymphoma 
was made.
Laboratory tests were within normal ranges. CT scan of  the 
neck, chest, abdomen, and pelvis showed no lymphadenopathy, 
hepatomegaly, or splenomegaly.
The patient was scheduled for surgical resection
Discussion
Primary cutaneous B-cell lymphomas comprise approximately 
20% of  cutaneous lymphomas. These lymphomas typically occur 
on the head or neck of  adults with a median age of  60 years and 
have a slight male predominance [1].
Few risk factors that promote the occurrence of  these lymphomas 
have been identified. Among these factors, HIV infection, EBV, 
HTLV or HHV, exposure to toxic. Questions also exist about a 
hereditary factor [2].
While PCFCCL as defined by the EORTC has been determined 
to generally lackbcl-2 protein expression and the t(14;18) 
characteristic of  nodal lymphoma, in North America they find 
that these features in a significant minority of  PCFL. Although 
this discrepancy may be caused by different diagnostic criteria, it 
maybe that European cases of  PFCL also lack bcl-2 protein and 
thet(14;18). Is there truly a difference in molecular pathogenesis 
between PCFL in North America and in Europe and how about 
Figure 1. Erythematous tumor in the temporal region.
Figure 2. Dermoscopy of  the tumor showing fine short linear vessel ( red arrow), curved linear vessel in a spermatozoa-like 
arrangement (blue arrow) and purpuric spots (black arrow) based on an erythematous background. 
 
Figure 3. Histology of  the tumor.
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Africa? [3].
Cutaneous follicular center B-cell lymphoma is an indolent 
tumor composed of  neoplastic follicular center cells comprising 
a mixture of  centrocytes (small or large, cleaved) and a variable 
number of  centroblasts (large,noncleaved and with a prominent 
nucleolus). Its growth pattern may be diffuse, follicular, or mixed, 
and it mainly affects the back and head, although it can appear at 
other sites, or even at several sites without the prognosis being 
necessarily worse [4].
PCFCCLs are usually diffuse and neoplastic cells show 
cytomorphology of  small and large cleaved centrocytes with 
centroblasts not in a cohesive sheet. Immunohistochemistry 
in PCFCCL shows positivity for B-cell markers CD20, CD22, 
CD79a, and Bcl-6 positivity and negativity for CD10, CD5, 
kappa, lambda, and Bcl-2 protein [3].
Therefore this case of  PCFCCL appears to be unusual because it 
seems to have a hereditary component; however, other studies are 
needed to confirm this hypothesis.
Our case also indicate that PCFCCL exhibits a characteristic 
dermoscopic pattern consisting of  fine short linear vessels and, 
vascular structures resembling spermatozoa which was described 
in early stage of  mycosis fungoides and never in PCFCCL [5]. 
However, prospective studies with long term follow-up are 
needed to determine the value of  these dermoscopic criteria .
PCFCCL rarely disseminates to extracutaneous sites and does not 
require an aggressive therapy.
Current treatment of  cutaneous B-cell lymphoma involves 
surgical resection and/or radiotherapy, intralesional or systemic 
interferon alfa, chemotherapy, or rituximab.
Surgical resection is a good option in the case of  an isolated lesion 
or a small number of  lesions grouped together in one area, and it 
can be combined with radiotherapy.
Radiotherapy is effective against the lesions caused by primary 
cutaneous B-cell lymphoma and doses generally range from 20 
Gy to 30 Gy. Treatment is well tolerated, and several authors 
consider it the first choice for localized lesions. 
Interferon alfa has immunomodulatory and antitumor properties 
and is used less commonly in cutaneous B-cell lymphoma than in 
cutaneous T-cell lymphoma. The standard dose ranges from 3 to 
9 million units subcutaneously per week. Interferon alfa can also 
be administered intralesionally.
Chemotherapy is not the treatment of  choice for cutaneous 
B-cell lymphoma and is reserved for the more aggressive forms, 
such as large-cell lymphoma, leg type. The CHOP regimen 
(cyclophosphamide, doxorubicin, vincristine, and prednisone) is 
the most widely used.
Rituximab is a chimeric monoclonal anti-CD20 antibody. CD20 
is a membrane phosphoprotein expressed only in B lymphocytes 
and is present in 95% of  B-cell lymphomas. Since 1997, rituximab 
has been used in the treatment of  non-Hodgkin B-cell lymphoma 
and has proven effective in cutaneous B-cell lymphoma. It can be 
administered intravenously or intralesionally [4].
PCFCCL have in general good prognosis with a median 5-year 
survival that exceeds 95 percent. 100 [6].
Conclusion
Our observation raises the genetic theory that needs to be 
confirmed by genomic studies on a large sample.
The dermoscopic features that we found also can help us for the 
diagnosis of  lymphoma in our daily practice, therefore, studies 
comparing dermoscopic criteria of  different types of  lymphoma 
are necessary to make the diagnosis of  PCFCCL easily.
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Figure 4. Immunohistochemistry showing positivity of  CD 20.
